Clinical Insights: September 22, 2020
Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval No new update. New Formulation Approval No new update. New Indication/Dosage Approval No new update. New Drug Shortage September 21, 2020 Indinavir (CRIXIVAN) Capsules (Discontinuation) September 18, 2020 Finasteride…
Clinical Insights: September 15, 2020
Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval GavretoTM (pralsetinib) Capsules – New Drug Approval – September 4, 2020 – Roche announced that the United States (US) Food and Drug Administration (FDA) has approved Gavreto™ (pralsetinib)…
Clinical Insights: September 8, 2020
Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval Onureg® (azacitidine) Tablets – New Drug Approval – September 1, 2020 – The Food and Drug Administration approved azacitidine tablets (Onureg®, Celgene Corporation) for continued treatment of patients…
Clinical Insights: September 1, 2020
Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval Winlevi® (clascoterone) Cream – New Drug Approval – August 27, 2020 – Cassiopea SpA announced that the United States Food and Drug Administration (FDA) approved Winlevi® (clascoterone cream…
Clinical Insights: August 25, 2020
Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval Kesimpta® (ofatumumab) Injection – New Drug Approval – August 20, 2020 – Novartis announced that the US Food and Drug Administration (FDA) has approved Kesimpta® (ofatumumab, formerly OMB157)…
Connect with RxStrategies at CHI@Home
RxStrategies’ Jonathan Ghenn, Rhodie Smith and Krista Scanlon will attend the virtual National Association of Community Health Centers’ CHI@Home, August 31 – September 1. CHI@Home sessions will reflect the challenges facing health centers during the pandemic. A wide range of opportunities for health centers to gain timely education and training will be available as…
Rhodie Smith to Present During 340B Health Webinar
RxSrategies’ Rhodie Smith, Vice President – Contract Pharmacy Sales, will present during the 340B Health webinar, “340B Updates from the Field: Series 4” on August 26. Insight will be provided, including: Tactics to successfully administer a conservative contract pharmacy program and implement an internal audit process Discuss best practices to help guide covered entities…
Clinical Insights: August 18, 2020
Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval EnspryngTM (satralizumab-mwge) Injection – New Drug Approval – August 17, 2020 – The U.S. Food and Drug Administration has approved EnspryngTM (satralizumab-mwge) for the treatment of neuromyelitis optica…
Clinical Insights: August 11, 2020
Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval OlinvykTM (oliceridine) Injection – New Drug Approval – August 7, 2020 – The U.S. Food and Drug Administration approved OlinvykTM (oliceridine), an opioid agonist for the management of…
Celebrate National Health Center Week 2020
RxStrategies is grateful for the support and quality care provided by Community Health Centers across the U.S., and we are honored to support their efforts. Especially as the COVID-19 pandemic continues to impact society, we recognize the health care professionals on the front-line who are the beacon of strength for the communities you serve. Learn…
Clinical Insights: August 4, 2020
Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval Monjuvi® (tafasitamab-cxix) Injection – New Drug Approval – July 31, 2020 – MorphoSys AG announced that the U.S. Food and Drug Administration (FDA) has approved Monjuvi® (tafasitamab-cxix) in…
Clinical Insights: July 28, 2020
Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval TecartusTM (brexucabtagene autoleucel) – New Drug Approval – July 24, 2020 – Kite, a Gilead Company announced that the U.S. Food and Drug Administration (FDA) has granted accelerated…